CITI/CALL/MERCK & CO./140/0.1/16.01.25 | Delayed Deutsche Boerse AG 18:41:09 21/05/2024 BST | ||
| 0.51 EUR | -3.77% |
|
| Current month | -7.27% | ||
| 1 month | +10.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 21/05/24 | 0.51 | -3.77% |
| 20/05/24 | 0.53 | +3.92% |
| 17/05/24 | 0.51 | 0.00% |
| 16/05/24 | 0.51 | -5.56% |
| 15/05/24 | 0.54 | +22.73% |
Delayed Quote Deutsche Boerse AG
Last update May 21, 2024 at 06:41 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Citi
|
| WKN | KH766W |
| ISIN | DE000KH766W0 |
| Date issued | 19/07/2023 |
| Strike | 140 $ |
| Maturity | 16/01/2025 (240 Days) |
| Parity | 10 : 1 |
| Emission price | 0.27 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.7 € |
|---|---|
| Lowest since issue | 0.01 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.8
USD
Average target price
141.6
USD
Spread / Average Target
+8.32%
- Stock Market
- Warrants
- Warrant
